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Abstract
Bikunin is a proteoglycan exhibiting broad-spectrum inhibitory activity against serine proteases and could
potentially suppress tumor cell invasion and metastasis. Here, we have successfully expressed recombinant human
bikunin (rh-bikunin) in Pichia pastoris and also established the purification procedure. Different fusion genes of h-
UTI and domain I, domain I and domain II, domain I, domain II and domain III of human serum albumin (HSA)
were inserted into expression vector pPICZaA. After expressed in shake flask, rh-bikunin was produced in an 30-L
fermenter and purified by affinity chromatography and cation exchange chromatography. The final expression
levels were 200 mg/L and we got totally 1.08 g (3650 IU/mg) of active purified rh-bikunin (purity is 98%) from 20 L
of fermentation broth. The rh-bikunin consists of unique form with molecular masses of 25 kDa, and has the same
N-terminals sequence as human native bikunin. This study provided a new method for high level expression of
active rh-bikunin by using HSA as fusion parter.
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Introduction
Bikunin, also being called urinary trypsin inhibitor
(UTI), contains two antiproteolytic Kunitz domains. The
protein is a proteoglycan ([Xu, Carr et al. 1998]), which
h a sam o l e c u l a rm a s so fa b o u t2 5k D ai n c l u d i n ga6 - 7
kDa chondroitin sulfate chain ([Pugia, Valdes Jr et al.
2007]; [Chi, Wolff et al. 2008]). Bikunin is synthesized
in the liver together with another plasma protein, a1-
microglobulin (a1-m), forming a precursor (a1-m/biku-
nin precursor, AMBP). As a kind of serine proteinase
inhibitor, bikunin exhibits broad inhibitory activity
against many proteases, such as trypsinase, chymotryp-
sin, leukocyte elastase, and fibrinolytic enzyme. More-
over, human bikunin hasn’t antigenicity to human and
has the characteristic of use safety, so it has been widely
used as a drug for patients with acute pancreatitis, acute
attack of chronic pancreatitis, acute circulation exhaus-
tion, tumor and shock ([H Inaba 1986]; [Okuhama, Shir-
aishi et al. 1999]; [Kobayashi, Suzuki et al. 2003]; [Yano,
Anraku et al. 2003]; [Molor-Erdene, Okajima et al.
2005]; [Qing xia 2005]; [Zhang, Liu et al. 2011]). The
bikunin has many advantages such as evident effect in
clinic, low side effect and low production cost. However,
due to the low content in urinary, difficult collection of
human urinary and high cost of purification, the bikunin
is limited to apply widely. To overcome these problems,
a promising alternative technique is to obtain recombi-
nant human bikunin by gene recombination.
The bikunin have been successfully cloned and
expressed in E. coli and Pichia pastoris ([Fritz 1995];
[Brinkmann, Weilke et al. 1997]; [Jian-qiu, Feng-qin et
al. 2008]). However, the yield of recombinant human
UTI (rh-UTI) in E. coli or P. pastoris is too low and the
uniform of protein doesn’t to be ensured. There hasn’t
been report about large scale production and animal
model examination so far. Therefore, the clinic value of
rh-UTI is difficult to be determined all the same.
Previous study showed that the use of human serum
albumin (HAS) as N-terminal fusions can be an effective
technique to express difficult proteins in mammalian
cells ([Carter, Zhang et al. 2010]; [Zhang, Carter et al.
2010]). So in this study, fusion genes of h-UTI and
domain I, domain I and domain II, domain I, domain II
and domain III of human serum albumin were inserted
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provided the original work is properly cited.into expression vector pPICZaA, respectively. Finally, all
plasmids were linearized for transformation into P. pas-
toris strain GS115. The h-UTI was highly expressed in
P. pastoris, which successfully solved the problems of
the uniform and low yield of h-UTI expressed in P.
pastoris.
Materials and methods
Strains, vectors and other reagents
The P. pastoris GS115, pPICZaA vector, and Zeocin
antibiotic were obtained from Invitrogen (CA, USA). P.
pastoris w e r eg r o w ni nY P Dm e d i u mc o n t a i n i n g1 0g / L
yeast extract, 20 g/L peptone, and 20 g/L D-glucose. To
prepare YPD plates, 2% agar (w/v) was added to the
YPD medium. YPD-Zeocin plates (1% yeast extract, 2%
peptone, 2% dextrose, 2% agar, and 0.1-0.2 mg/mL Zeo-
cin) were used for selecting multicopy transformants.
The P. pastoris cells were cultured in BMGY medium
(1% yeast extract, 2% peptone, 1% glycerol, 400 μg/L
biotin, and 0.1 M potassium phosphate, pH 6.0) for
growth and in BMMY medium (1% yeast extract, 2%
peptone, 400 μg/L biotin, 1% methanol, and 0.1 M
potassium phosphate, pH 6.0) for induction. All primers
were synthesized by SangonB i o t e c h n o l o g yC o r p .
(Shanghai, China). All restriction enzymes, DNA marker,
synthesized genes (human BSA-UTI fusions) and pro-
tein marker were purchased from Takara (Dalian,
China). The standard human UTI, trypsin purchased
from Sigma-Aldrich (St. Louis, USA).
Construction of expression vector pPICZa-HSA-UTI
Construction of rh-bikunin expression vector was based
on pPICZaA vector. The synthesized human serum
albumin (HSA) gene containing different domains were
added 6 × His tag, several Gly linkers and the recogni-
tion site of Enterokinase (EK) at the C-terminal (as
shown in Figure 1). The synthesized HSA gene and UTI
gene were ligated to pMD18-T vector. The recombinant
plasmids pMD-HSA-UTI were digested with Xho Ia n d
Not I and then inserted into the same site of pPICZaA.
The recombinant expression plasmids were designated
as pPICZa-UTI, pPICZa-D1-UTI, pPICZa-D2-UTI,
pPICZa-D12-UTI and pPICZa-D123-UTI, respectively.
Transformation of P. pastoris and selection of high-level
expression
The five Sac I restriction endonuclease linearized
recombinant expression vectors were introduced into P.
pastoris GS115 by electroporation using a Micropulser
(Bio-Rad, USA) according to the manual, respectively.
Figure 1 Maps of fusion genes. Plasmid pPICZaA was used as a parent vector for constructing these fusions. D1, D2 and D3 represent
different domain of human serum albumin (HSA) gene. Several Gly residues designed as linker. EK represent the site of enterokinase. UTI
represent the gene of urinary trypsin inhibitor.
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extract peptone dextrose (YPD) agar plates containing
Zeocin (0.5 mg/mL). After the multicopy transformants
appeared, single clone was cultured in 5 mL BMGY
medium at 28°C with shaking at 250 rpm for 24 h. The
cells were then centrifuged and resuspended in 5 mL
BMMY medium to induce expression for 4 days. The
culture medium (0.5 mL) was sampled per day and cen-
trifuged at 4°C, 10,000 rpm for 5 min. Cell pellet and
supernatant were separated. The supernatant was tested
for UTI activity and cell pellet was used for genomic
DNA analysis. pPICZa A blank plasmids were also
transformed as a negative control.
Optimization of fermention conditions by shake-flask
mode
In order to determine the effect of pH on the expression
level of rh-UTI, the BMGY media was performed at dif-
ferent pH values (pH 4.0, 5.0, 5.5, 6.0, 6.5, 7.0). In order
to determine the effect of feeding mode on the expres-
sion level of rh-UTI, inorganic salt, peptone, yeast
extracts and glycerol was used as the carbon sources in
BMGY media by continuous fed-batch mode,
respectively.
High-density fermentation
As t o c kc u l t u r eo fP. pastoris was grown to an A600 of
3-6 in a 5-L shake flask containing 2 L YPD. The shake
flask culture was used to inoculate an 30-L fermenter
(Bioengineering, AG) containing 20 L of fermentation
basal salts medium FM22 supplemented with PTM1
trace salts (1.1 mL of stock solution/L) and biotin (0.4
mL of the stock solution/L). The dissolved oxygen level
(DO) was set at 30% and the stirring rate was 700 rpm.
The pH of the medium was maintained 6.0-6.5 by auto-
matic addition of 5 N NH4OH and 1 M phosphoric acid
and 5% antifoam as required. Temperature was main-
tained at 30°C. The initial cultivation terminated when
all glycerol was consumed (about 14 h) at batch phase.
Continuous 2% peptone and 1% yeast extract feeding
were carried out for about 6 h in the subsequent fed-
batch phase. To induce rh-UBI expression, 100% metha-
nol was fed at 3 mL/h/L for 50 h. Sampling of the cul-
ture medium at the end of each phase was performed
for assay of rh-bikunin activity.
Purification of rh-UBI and assay of trypsin inhibitory
activity
The supernatant was collected by centrifugation, 5 M
NaCl and phosphate buffer was added to a final concen-
tration of 1 M and 50 mM, respectively. Finally, the pH
value was also adjiusted to 7.4 with NaOH. Then the
treated supernatant was was clarified with a 0.45 μm
cellulose membrane. The supernatant was purified with
chelating sepharose affinity chromatography and Q
sepharose F. F. anion exchange chromatography in turn.
Then after digested by enterokinase, the sample was iso-
lated and purified by chelating sepharose affinity chro-
matography and SP sepharose F.F cation exchange
chromatography. The purity of each step protein sample
was checked by SDS-PAGE. The final rh-bikunin pro-
tein was stored at -20°C for further assay of trypsin inhi-
bitory activity accroding to previous study ([Page,
Quillien et al. 2000]; [Wang, Yan et al. 2008]).
Carbohydrate digestion and amino-terminal sequence
The amino-terminal sequence of rh-bikunin was deter-
mined automated Edman degradation method (Shanghai
Sangon Biological Engineering Technology & Services
CO., Ltd). N-linked glycosylation was assayeded by
digestion of the protein with N-glycosidase F. Protein
samples (20 μg )w e r eb o i l e df o r5m i ni n1 %( w / v )S D S
and 50 mM DTT. Samples were then diluted to 0.1%
SDS, 5 mM DTT, 20 mM sodium phosphate (pH 7.4),
25 mM EDTA, and 2% Triton X-100. N-glycosidase F
(0.8 U) was added and samples w e r ei n c u b a t e da t3 7 ° C
overnight. Deglycosylation of the protein was assessed
by a shift in electrophoretic mobility on SDS-PAGE
analysis.
Results
Construction of recombinant plasmids and identification
of transformed colonies
Five plasimds containing of different domain of HSA
gene were constructed (Figure 1). DNA sequence analy-
sis of the five recombinant expression vectors pPICZa-
HSA-UTI demonstrated that cDNA encoding human
bikunin and human serum albumin (HSA) gene were
correctly inserted into pPICZaA vector. The recombi-
nant expression vectors were then linearized with Sac I
and introduced into P. pastoris strain GS115. Agarose
gel electrophoresis of the PCR products showed that
cDNA encoding bikunin was indeed integrated into the
the P. pastoris genome. However, there were no visible
bands from the control sample which were transformed
with pPICZaA blank plasmid.
Shake-flask expression of rh-bikunin
Three clonies containing of pPICZa-D12-UTI showed
the highest expression level in shake-flask expression
than other recombinant plasmids (Data not shown). The
effects of pH value and carbon sources on the expres-
sion level of rh-UTI in P. pastoris/pPICZa-D12-UTI
were also investigated by shake-flask fermentation. The
pH value of BMGY media was adjusted to the desired
value. The results showed that the expression levels of
rh-bikunin were different when pH of medium varied
from 4.0-7.0. When the pH value was 6.0-6.5, the
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other pH values. In order to determine the effect of
feeding mode on the expression level of rh-UBI, inor-
ganic salt, peptone, yeast extracts and glycerol was used
as the carbon sources in BMGY media by continuous
fed-batch mode, respectively. The results displayed that
when the inorganic salt, peptone and yeast extracts were
used as the carbon sources in BMGY media, the expres-
sion level of rh-UBI was higher than that of glycerol.
Therefore, the optimal pH (6.0-6.5) and carbon sources
(inorganic salt, peptone or yeast extracts) were selected
as shake-flask condition and further fermentation (data
not shown).
High-density fermentation and purification of the
recombinant protein
Under optimal conditions (pH 6.0, 30°C, and DO set at
about 30%), the highest optical density and cell wet
weight were obtained after 50 h of methanol induction.
The expression level was also reached to 200 mg/L. The
rh-bikunin solution was purified with chelating sephar-
ose affinity chromatography and Q sepharose F.F. anion
exchange chromatography in turn. Then after digested
by enterokinase, the sample was isolated and purified by
chelating sepharose affinity chromatography and SP
sepharose F.F cation exchange chromatography. The
protein recovery of the rh-bikunin at the different purifi-
cation steps were summarized in Table 1. Following
these processes, we could get totally 1.08 g of purified
rh-bikunin (purity is 98%) from 20 L culture medium as
revealed by SDS-PAGE (Figure 2 and Table 1). Rh-biku-
nin was secreted in the medium after induction and a
final concentration of approximately 3650 IU/mg was
obtained, which was 1.46 times higher than that of
native human urinary bikunin (2500 IU/mg).
Characterization of purified rh-UTI
According to SDS-PAGE analysis (Figure 2, Lanes S3
and S4), rh-UTI migrated as a single band. The molecu-
lar masses based on protein migration rates in SDS gel
were 23~24 kDa. However, double band was observed
in other previous study ([Falkenberg, Wester et al.
2001]; [Wang, Yan et al. 2008]). The mass of rh-UTI
increased by approximately 5 kDa after treatment with
N-glycosidase F (Figure 3, Lanes 3, 4 and 5). On the
other hand, the N-terminal amino acid sequence of rh-
UTI was also identical to the N-terminus of native
human bikunin (Figure 4, Ala-Val-Leu-Pro), which
demonstrating correct processing ([Kakizaki, Takahashi
et al. 2007]).
Discussion
The expression system of yeast P. pastoris has several
advantages, including the use of the alcohol oxidase I
(AOX1) gene promoter, the ability of the cells to be cul-
tivated at high density, a simplified purification proce-
dure for secreted heterologous proteins, and
modifications of foreign proteins ([Wang, Yan et al.
2008]). So, the expression system of yeast P. pastoris
was used for bikunin expression. On the other hand,
several parameters such as clone selection, codon opti-
mization, fusion partners and culture conditions play a
important role in obtaining high yields of protein. So, in
order to optimize the level of protein production experi-
ment, we evaluated the role of codon optimization,
fusion partners and culture conditions in obtaining high
yields of bikunin.
Firstly, codon bias is an intrinsic problem in heterolo-
gous protein production and needs to be taken into
account in the experimental design. So, the synthesized
human serum albumin (HSA) gene was used in this
study. Secondly, previous study showed that the use of
human serum albumin (HAS) as N-terminal fusions can
be an effective technique to express difficult proteins in
mammalian cells ([Carter, Zhang et al. 2010]; [Zhang,
Carter et al. 2010]). So in this study, fusion genes of h-
UTI and domain I, domain I and domain II, domain I,
domain II and domain III of human serum albumin
were inserted into expression vector pPICZaA, respec-
tively (As shown in Figure 1). The results showed that
three clonies containing of pPICZa-D12-UTI (contain-
ing domain I and domain II) showed the highest expres-
sion level in shake-flask expression than other
recombinant plasmids. Thirdly, the effects of pH value
Table 1 Summary of purification process of rh-UTI
Purification step Volume
(mL)
Protein concentration
(mg/L)
rh-UTI
(mg)
Protein recovery (%)
Supernatant 20,000 200 4,000
Ultrafiltrated 3,000 1.20 3,600 90.0
Chelating sepharose 600 4.75 2,850 71.25
Q sepharose F.F. 350 6.68 2,338 58.45
Chelating sepharose after digested by Enterokinase 1,500 0.90 1,350 33.75
SP sepharose F.F 220 4.91 1,080 27.0
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P. pastoris/pPICZa-D12-UTI were also investigated by
shake-flask fermentation. Rh-bikunin was secreted in the
medium after induction and the final expression levels
were 200 mg/L. As a result, we got totally 1.08 g (3650
IU/mg) of active purified rh-bikunin (purity is 98%)
from 20 L of fermentation broth, which was 1.46 times
higher than that of native human urinary bikunin (2500
Figure 2 SDS-PAGE of the recombinant rh-UTI in different step of purification. S1, Chelating sepharose affinity chromatography; S2, Q
sepharose F.F. anion exchange chromatography; S3, Chelating sepharose affinity chromatography after digested by enterokinase; SP sepharose F.
F cation exchange chromatography.
Figure 3 Deglycosylation of rh-UTI. Purified recombinant human bikuninwas treated with N-glycosidase F and examined by SDS-PAGE. Lanes
1, negative control; Lanes 2, untreated rh-UTI; Lanes 3, 4 and 5, after treatment with N-glycosidase F. For rh-UTI, the mass, calculated from the
migration distance in SDS-PAGE, increased by approximately 5 kDa after treatment with N-glycosidase F (Lanes 3, 4 and 5).
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methods, we sucessfully expressed active rh-bikunin at
the high level.
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